Amylyx Pharmaceuticals, Inc. (AMLX) Earnings
|
Expand Research on AMLX
| Next EPS Date | 8/6/26 | EPS Growth Rate | +23.9% |
|---|---|---|---|
| Average EPS % Beat Rate | +4.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -5.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/6/26  |
Q226 | N/A | -$0.35 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/7/26 | Q126 | -$0.37 | -$0.33 | -$0.04 | N/A | N/A | N/A |  | | Details | |
| 3/3/26 | Q425 | -$0.30 | -$0.34 | +$0.04 | N/A | $-52000000000 | N/A | | | Details | |
| 11/6/25 | Q325 | -$0.37 | -$0.45 | +$0.08 | N/A | $52K | N/A | | | Details | |
| 8/7/25 | Q225 | -$0.46 | -$0.46 | $0.00 | N/A | N/A | N/A | | | Details | |
| 5/8/25 | Q125 | -$0.42 | -$0.62 | +$0.20 | N/A | N/A | N/A | | | Details | |
| 3/4/25 | Q424 | -$0.55 | -$0.56 | +$0.01 | N/A | N/A | N/A | | | Details | |
| 11/7/24 | Q324 | -$1.07 | -$0.70 | -$0.37 | $416K | N/A | N/A | | | Details |
